Comparison of ezetimibe and atorvastatin versus atorvastatin alone on short-term major adverse cardiac events after percutaneous coronary intervention, a double-blind placebo-controlled randomized clinical trial.
Saved in:
| Title: | Comparison of ezetimibe and atorvastatin versus atorvastatin alone on short-term major adverse cardiac events after percutaneous coronary intervention, a double-blind placebo-controlled randomized clinical trial. |
|---|---|
| Authors: | Farshidi H; Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.; Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran., Bijani B; Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran., Sobhani SA; Department of Pathology, School of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran., Dastsouz F; Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran., Abbaszadeh S; Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran. sh.abbaszadeh@hums.ac.ir. |
| Source: | Trials [Trials] 2025 Mar 28; Vol. 26 (1), pp. 108. Date of Electronic Publication: 2025 Mar 28. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Comparative Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
